Body Fat: Why Location Matters More Than Amount

Body fat is usually described as storage — surplus energy put aside for later, inert until burned. That description is about fifty years out of date and it produces most of the confusion about weight and health.

Adipose tissue is an active endocrine organ. It manufactures hormones, releases inflammatory signals, communicates with the brain, the liver and the muscles, and behaves differently depending on where in the body it sits. Two people carrying identical amounts can face substantially different risk.

🔬 What it is made of

Adipose tissue is built from cells called adipocytes, each holding a droplet of stored fat that can occupy the great majority of the cell’s volume, pushing everything else to the rim. Between them run blood vessels, nerves and immune cells — it is a living, supplied, innervated tissue rather than a passive deposit.

One property has consequences that people find genuinely surprising. The number of fat cells is largely settled by early adulthood and stays roughly constant thereafter. Around a tenth are replaced each year, but the total remains stable.

So gaining and losing weight is mostly cells changing size rather than appearing and disappearing. Lose a substantial amount of weight and you still have the same number of fat cells, now emptied. This is part of why weight regain is so much easier than weight loss, and why the body appears to defend a previous weight rather than accepting a new one.

At the extremes the rule bends — in severe obesity, existing cells reach their limit and new ones are recruited — and for most people, most of the time, it holds.

🗺️ The two compartments

The last row of that table is worth pausing on. A soft abdomen you can grasp a handful of is largely subcutaneous. A firm, rounded, distended abdomen that does not pinch is largely visceral — and it is the one that matters.

The second-to-last row contains the encouraging part. Visceral fat is the most metabolically active and therefore the first to be mobilised when weight comes down. Which is why quite modest weight loss produces disproportionate improvements in blood sugar, blood pressure and liver tests, well before anyone notices a change in appearance. Losing five percent of body weight can shift the numbers substantially while barely altering how you look.

📏 What to measure instead

Body mass index has been the standard for decades and its limitations are well known: it cannot distinguish muscle from fat, it says nothing about where fat is located, and the thresholds do not transfer between populations.

Two simpler measurements do more.

Waist circumference. Measured at the midpoint between the lowest rib and the top of the hip bone, at the end of a normal breath out, without pulling the tape tight or holding the stomach in. Risk begins to rise above roughly 94 centimetres in men and 80 in women, and is substantially raised above 102 and 88. Those figures are lower for people of South Asian, Chinese and Japanese descent, who accumulate visceral fat at lower body weights.

Waist against height is simpler still and arguably better, because it needs no population-specific thresholds: keep your waist below half your height. Someone 175 centimetres tall aims for a waist under 87. It applies across ages and ethnicities and requires no chart.

📡 The organ that talks

Fat tissue releases signalling molecules that reach the brain, liver, muscle and blood vessels. Three matter most.

Leptin

Reports the size of energy stores to the brain and suppresses appetite. More fat produces more leptin — so obesity involves high leptin rather than low. The brain stops responding to the signal, a state called leptin resistance, which is why the discovery of the hormone did not produce the treatment everyone expected.

Adiponectin

Improves insulin sensitivity and reduces inflammation, and behaves counterintuitively: levels fall as fat mass rises. So the protective signal weakens exactly when it is most needed.

Inflammatory messengers

Visceral fat becomes infiltrated with immune cells and releases a steady stream of inflammatory signals. Not the acute inflammation of an injury, but a low-grade, permanent, body-wide version — which is the mechanism connecting excess visceral fat to insulin resistance, to fatty liver, to blood vessel damage and to raised blood pressure.

That last item is the link between carrying weight around the middle and the conditions that follow it. It is not that fat is heavy. It is that visceral fat is chemically active in an unhelpful direction, continuously, and pointed directly at the liver.

🔥 The other kind of fat

Most adipose tissue is white and stores energy. A second type does the opposite.

Brown adipose tissue is packed with mitochondria — which give it the colour — and contains a protein allowing those mitochondria to burn fuel producing heat instead of usable energy. It exists to keep newborns warm, since infants cannot shiver.

It was long assumed to disappear in adulthood. Imaging studies showed otherwise: most adults retain deposits around the neck, collarbones and spine, activated by cold exposure. The quantity is inversely related to body weight and to age — leaner and younger people have more.

The obvious question is whether it can be exploited, and honesty is required. Cold exposure activates it, and regular exposure appears to increase it. The energy involved is real and modest. Attempts to turn this into a treatment have not yet produced one, and products marketed on the basis of activating brown fat are ahead of the evidence by a considerable distance.

🎯 Two things fat does not do

It does not come off where you exercise it. Abdominal exercises strengthen abdominal muscles and do not preferentially remove abdominal fat. When fat is mobilised, it is released from stores throughout the body according to a pattern set largely by genetics and hormones, not by which muscle is working. This has been tested repeatedly, including studies exercising one limb and measuring both, and the result is consistent. Whole-body exercise and an energy deficit reduce fat; the body decides the order.

It is not optional. The condition in which fat tissue is absent or fails to develop produces severe metabolic disease — extreme insulin resistance, dangerously high triglycerides, fatty liver — in people who are visibly thin. Without anywhere safe to put surplus energy, it is deposited in the liver and muscle instead, where it does far more damage. That condition is the clearest demonstration that adipose tissue is a necessary organ, and that the problem with excess is a matter of quantity and placement rather than of the tissue itself.

⚖️ Why lost weight comes back

This deserves stating plainly because the usual explanation blames the wrong thing.

After weight loss, several measurable changes appear and persist:

• Leptin falls further than the weight loss predicts, so the brain receives a signal of famine rather than of a smaller body
• Hunger hormones rise, increasing appetite
• Resting energy expenditure falls below what the new, smaller body should require — the body becomes more economical than its size accounts for
• Fat cells remain in place, emptied, ready to refill

These changes have been shown to persist for years after weight loss, not weeks. Someone maintaining a reduced weight is hungrier than someone who was always that weight, and burning less energy, indefinitely.

That is a biological defence of a previous weight, not a failure of character. It explains why maintenance is harder than loss, why regain is so common, and why approaches requiring permanent vigilance against permanent hunger tend to fail. It is also why the useful target is often a modest, sustained reduction rather than a dramatic one — five to ten percent held for years does considerably more for the numbers than twenty percent lost and regained.

🧍 Normal weight, wrong distribution

A group is missed entirely by weight-based screening: people whose body mass index sits comfortably in the normal range while carrying a substantial amount of visceral fat.

They appear slim, are told their weight is fine, and have the metabolic profile of someone considerably heavier — insulin resistance, fatty liver, raised triglycerides.

It is more common in people of South Asian descent, in whom metabolic disease appears at lower body weights, which is why waist thresholds are set lower for that group. It is also common in people who are thin but sedentary, with little muscle, and in those who lost weight rapidly and regained it as visceral fat.

The practical implication is that a normal weight does not exclude the problem, and that a waist measurement is worth taking regardless of what the scale says. Fatigue, raised liver enzymes or a borderline glucose in a slim person are worth investigating rather than dismissing on the basis of appearance — the article on raised liver enzymes covers the commonest way this comes to light.

📊 What is worth checking

If waist measurement is raised, or if there are other reasons for concern, the panel that matters is short and inexpensive.

Those five together identify almost everyone whose fat distribution is doing them harm, and they cost very little.

🏃 What actually shifts visceral fat

The encouraging finding is that this compartment responds first and fastest.

Any sustained energy deficit reduces visceral fat preferentially, whatever dietary approach produces it.

Exercise reduces it beyond what weight loss alone explains. People who exercise without losing weight still reduce visceral fat measurably, which is among the strongest arguments for activity independent of the scale.

Reducing sugary drinks and refined carbohydrate has a particular effect on liver fat specifically.

Sleep matters more than expected. Short sleep raises hunger hormones, worsens insulin sensitivity and is associated with visceral accumulation independently of intake.

Alcohol contributes directly to both visceral and liver fat.

Muscle helps, because it provides somewhere for glucose to go and improves insulin sensitivity independently of fat loss.

💊 Where medication fits

Medication has a place where lifestyle change has been genuinely attempted and the risk remains significant, and the history of this category demands caution.

Several weight-loss drugs have been withdrawn by regulators after approval — some for causing heart attacks and strokes, others for severe psychiatric effects including suicidality. They were effective at reducing weight. That was never the question, and it is worth remembering when assessing anything promising rapid results.

Orlistat works differently from all of them, and its mechanism is the reason it is still available. It blocks the enzyme digesting dietary fat, so roughly a third of the fat eaten passes through unabsorbed. It acts entirely within the gut and is barely absorbed into the body, which is why it lacks the cardiovascular and psychiatric effects that removed the others.

Its effect is modest — a few kilograms more than diet alone over a year — and its side effects are proportional to how much fat is eaten, so the drug effectively enforces a lower-fat diet through immediate feedback. It also reduces absorption of vitamins A, D, E and K, so a supplement is advised, taken at a different time of day.

Options are stocked in the weight-loss range, including Slimtop, Orligal, Xenical and Orlijohn — all orlistat, at prices differing by nearly half for the same substance and strength, which is worth comparing before ordering. The article on safe weight loss covers how it fits alongside everything else.

🩺 When to seek advice

• Waist above half your height, whatever your weight
• A firm protruding abdomen that does not pinch
• Normal weight with fatigue, raised liver enzymes or borderline glucose
• Rapid abdominal enlargement over weeks — that is not fat and needs assessing
• Snoring with pauses in breathing, which travels with visceral fat and worsens it
• Excessive thirst, passing urine frequently, or unexplained weight loss
• A family history of early heart disease or diabetes, which lowers the threshold for checking
• Weight regained repeatedly after loss — there is a biological explanation and better approaches than trying harder

❓ Frequently asked questions

📑 Sources and editorial

• Research on adipocyte turnover and the stability of fat cell number in adults
• Literature on the portal hypothesis and visceral adipose drainage to the liver
• Evidence on gluteofemoral fat distribution and metabolic protection
• Studies of waist circumference and waist-to-height ratio as predictors of cardiometabolic risk
• Ethnicity-specific waist thresholds in South Asian and East Asian populations
• Research on leptin resistance, adiponectin and adipose-derived inflammatory signalling
• Imaging studies confirming functional brown adipose tissue in adults
• Trials of spot reduction and regional fat mobilisation
• Longitudinal studies of metabolic adaptation and hormonal changes persisting after weight loss
• Literature on lipodystrophy and ectopic fat deposition
• Regulatory withdrawal notices for sibutramine and rimonabant
• Prescribing information for orlistat, including fat-soluble vitamin absorption
• Related reading: safe weight loss, raised liver enzymes, fitness and weight
• RXshop Editorial Team — reviewed by Daniel Kim, MD, Endocrinologist